Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director

Myovant Sciences Ltd. (MYOV) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/10/2023 4 Valente Nancy (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 3,673 shares @ $0
Disposed/sold 36,892 options to buy @ $22.71, valued at $837.8k
03/10/2023 4 POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 3,673 shares @ $0
Disposed/sold 45,000 options to buy @ $26.17, valued at $1.2M
Disposed/sold 58,608 options to buy @ $7.65, valued at $448.4k
Disposed/sold 21,603 options to buy @ $21.47, valued at $463.8k
Disposed/sold 21,096 options to buy @ $22.71, valued at $479.1k
03/10/2023 4 Merendino Lauren (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 21,791 shares @ $0
Disposed/sold 147,747 shares @ $0
Disposed/sold 123,300 options to buy @ $17.88, valued at $2.2M
Disposed/sold 103,703 rights @ $0
03/10/2023 4 Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 20,724 shares @ $0
Disposed/sold 181,972 shares @ $0
Disposed/sold 165,192 options to buy @ $21.83, valued at $3.6M
Disposed/sold 111,111 rights @ $0
03/10/2023 4 Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 95,675 shares @ $0
Disposed/sold 321,924 shares @ $0
Disposed/sold 306,427 options to buy @ $20.54, valued at $6.3M
Disposed/sold 208,218 options to buy @ $17.88, valued at $3.7M
Disposed/sold 204,808 options to buy @ $11.33, valued at $2.3M
Disposed/sold 134,567 rights @ $0
03/10/2023 4 Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 113,145 shares @ $0
Disposed/sold 241,158 shares @ $0
Disposed/sold 220,000 options to buy @ $7.78, valued at $1.7M
Disposed/sold 87,050 options to buy @ $7.78, valued at $677.2k
Disposed/sold 152,110 options to buy @ $7.78, valued at $1.2M
Disposed/sold 170,396 options to buy @ $8.08, valued at $1.4M
Disposed/sold 90,310 options to buy @ $17.88, valued at $1.6M
Disposed/sold 111,111 rights @ $0
03/10/2023 4 Gulfo Adele M. (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 3,673 shares @ $0
Disposed/sold 45,000 options to buy @ $11.17, valued at $502.7k
Disposed/sold 21,603 options to buy @ $21.47, valued at $463.8k
Disposed/sold 21,096 options to buy @ $22.71, valued at $479.1k
03/10/2023 4 GUINAN MARK (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 3,673 shares @ $0
Disposed/sold 45,000 options to buy @ $19.71, valued at $887k
Disposed/sold 58,608 options to buy @ $7.65, valued at $448.4k
Disposed/sold 21,603 options to buy @ $21.47, valued at $463.8k
Disposed/sold 21,096 options to buy @ $22.71, valued at $479.1k
03/10/2023 4 Curran Terrie (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 3,673 shares @ $0
Disposed/sold 33,846 options to buy @ $11.3, valued at $382.5k
Disposed/sold 11,154 options to buy @ $12.68, valued at $141.4k
Disposed/sold 22,500 options to buy @ $13.14, valued at $295.7k
Disposed/sold 22,500 options to buy @ $24.25, valued at $545.6k
Disposed/sold 5,250 options to buy @ $7.65, valued at $40.2k
Disposed/sold 21,603 options to buy @ $21.47, valued at $463.8k
Disposed/sold 21,096 options to buy @ $22.71, valued at $479.1k
03/10/2023 4 Arjona Ferreira Juan Camilo (Chief Medical Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed/sold 86,602 shares @ $0
Disposed/sold 160,082 shares @ $0
Disposed/sold 155,300 options to buy @ $7.78, valued at $1.2M
Disposed/sold 63,717 options to buy @ $7.78, valued at $495.7k
Disposed/sold 65,863 options to buy @ $7.78, valued at $512.4k
Disposed/sold 134,464 options to buy @ $8.08, valued at $1.1M
Disposed/sold 79,472 options to buy @ $17.88, valued at $1.4M
Disposed/sold 103,703 rights @ $0
03/10/2023 4 Sumitomo Chemical Co., Ltd. (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Bought 51,599,200 shares @ $27, valued at $1393.2M
03/06/2023 4 Sumitomo Chemical Co., Ltd. (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Disposed of 4,243,005 shares @ $0
Acquired 1 options to buy @ $27, valued at $27
01/20/2023 4 Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 1,272 shares @ $26.89, valued at $34.2k
01/20/2023 4 Merendino Lauren (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 2,008 shares @ $26.89, valued at $54k
01/20/2023 4 Marek David C (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 8,037 shares @ $26.89, valued at $216.1k
01/20/2023 4 Arjona Ferreira Juan Camilo (Chief Medical Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 1,109 shares @ $26.89, valued at $29.8k
01/05/2023 4 Arjona Ferreira Juan Camilo (Chief Medical Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 2,251 shares @ $26.9, valued at $60.6k
01/05/2023 4 Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 2,779 shares @ $26.9, valued at $74.8k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Curran Terrie (Director) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 9,859 shares @ $0
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/20/2022 4 Mehra Uneek (Principal Financial Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 9,243 shares @ $18.86, valued at $174.3k
08/16/2022 4 Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Granted 124,780 shares @ $0
Sold 31,214 shares @ $18.23, valued at $569k
07/20/2022 4 Lang Matthew (General Counsel & Corp. Secy.) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 1,935 shares @ $12.87, valued at $24.9k
07/20/2022 4 Merendino Lauren (Chief Commercial Officer) has filed a Form 4 on Myovant Sciences Ltd.
Txns: Sold 1,704 shares @ $12.87, valued at $21.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy